Naoshi Kondo
About
In The Last Decade
Naoshi Kondo
30 papers receiving 861 citations
Peers
Comparison fields: 5 of 79
- Ophthalmology 623
- Radiology, Nuclear Medicine and Imaging 372
- Molecular Biology 345
- Immunology 68
- Organic Chemistry 51
Countries citing papers authored by Naoshi Kondo
This map shows the geographic impact of Naoshi Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoshi Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoshi Kondo more than expected).
Fields of papers citing papers by Naoshi Kondo
This network shows the impact of papers produced by Naoshi Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoshi Kondo. The network helps show where Naoshi Kondo may publish in the future.
Co-authorship network of co-authors of Naoshi Kondo
This figure shows the co-authorship network connecting the top 25 collaborators of Naoshi Kondo. A scholar is included among the top collaborators of Naoshi Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoshi Kondo. Naoshi Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 83 | |
| 2 | 97 | |
| 3 | 21 | |
| 4 | Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy. | 6 |
| 5 | Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2). | 18 |
| 6 | 22 | |
| 7 | 21 | |
| 8 | Nrf2 Signaling is Activated After Cigarette Smoke Extract Exposure in Rpe Cells in vitro and in vivo | 1 |
| 9 | Advanced Glycation Endproducts (AGEs) Favor LDL Retention in the Fundus | 1 |
| 10 | 53 | |
| 11 | Coding variant Met72Thr in the PEDF gene and risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. | 15 |
| 12 | 22 | |
| 13 | 21 | |
| 14 | 65 | |
| 15 | 11 | |
| 16 | 26 | |
| 17 | Autologous Plasmin Assisted Vitrectomy for Stage 5 Retinopathy of Prematurity | 1 |
| 18 | 10 | |
| 19 | 16 | |
| 20 | 39 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.